PLH-3481

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NamePLH-3481
Drug Alias NamePLH-3481
ClassificationOther
Mechanisms of ActionEukaryotic translation initiation factor 2-alpha kinase 4 modulators
TargetsEukaryotic translation initiation factor 2-alpha kinase 4
Therapy Area/IndicationsSquamous Cell Carcinoma of Head and Neck
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSeoul National University
China Registration ClassN/A

Develop Information

Active CompaniesSeoul National University
Inactive CompaniesN/A
Active IndicationsSquamous Cell Carcinoma of Head and Neck
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A